FDA Issues Public Safety Notification On Exosome Products
On December 6, 2019, the FDA warned the public, especially patients, health care practitioners, and clinics, of multiple recent reports of serious adverse events experienced by patients in Nebraska who were treated with unapproved products marketed as containing exosomes. These reports were brought [...]